BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37183645)

  • 1. [Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of 
Small Cell Lung Cancer].
    Wu Y; Zhao J; Wang M
    Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):303-309. PubMed ID: 37183645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Therapies and Biomarkers: Are We Ready for Personalized Treatment in Small Cell Lung Cancer?
    Zhang B; Birer SR; Dvorkin M; Shruti J; Byers L
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-10. PubMed ID: 33979194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell lung cancer: where do we go from here?
    Byers LA; Rudin CM
    Cancer; 2015 Mar; 121(5):664-72. PubMed ID: 25336398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtyping of small-cell lung cancer based on mutational signatures with different genomic features and therapeutic strategies.
    Wang H; Wu S; Li Z; Zhang C; Shang X; Zhao C; Li Z; Lin J; Guo J; Wang Z
    Cancer Sci; 2023 Feb; 114(2):665-679. PubMed ID: 36178064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Therapeutic Options for Small Cell Lung Cancer.
    Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
    Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Are the Biomarkers for Immunotherapy in SCLC?
    Longo V; Catino A; Montrone M; Pizzutilo P; Annese T; Pesola F; Marech I; Cassiano S; Ribatti D; Galetta D
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent Advances and Future Strategies for Small Cell Lung Cancer].
    Shao W; Wang X; Liu D
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):421-426. PubMed ID: 28641701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential subtype-specific therapeutic approaches in small cell lung cancer.
    Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
    Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territory.
    Kashima J; Okuma Y
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):386-395. PubMed ID: 35569741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Small cell lung cancer heterogeneity and molecular subtypes: biological and clinical relevance].
    Berta J; Ferencz B; Horváth L; Fillinger J; Lantos A; Bogos K; Rényi-Vámos F; Megyesfalvi Z; Döme B
    Magy Onkol; 2023 Sep; 67(3):181-192. PubMed ID: 37768117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subtyping of small cell lung cancer.
    Liang J; Guan X; Bao G; Yao Y; Zhong X
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):450-462. PubMed ID: 35609720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification.
    Caliman E; Fancelli S; Petroni G; Gatta Michelet MR; Cosso F; Ottanelli C; Mazzoni F; Voltolini L; Pillozzi S; Antonuzzo L
    Lung Cancer; 2023 Jan; 175():88-100. PubMed ID: 36493578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer.
    Park S; Hong TH; Hwang S; Heeke S; Gay CM; Kim J; Jung HA; Sun JM; Ahn JS; Ahn MJ; Cho JH; Choi YS; Kim J; Shim YM; Kim HK; Byers LA; Heymach JV; Choi YL; Lee SH; Park K
    EBioMedicine; 2024 Apr; 102():105062. PubMed ID: 38492534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cells - big issues: biological implications and preclinical advancements in small cell lung cancer.
    Solta A; Ernhofer B; Boettiger K; Megyesfalvi Z; Heeke S; Hoda MA; Lang C; Aigner C; Hirsch FR; Schelch K; Döme B
    Mol Cancer; 2024 Feb; 23(1):41. PubMed ID: 38395864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances of immunotherapy in small cell lung cancer].
    Liu J; Zhang S; Li H; Cheng Y
    Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):474-80. PubMed ID: 24949688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCLC-State of the Art and What Does the Future Have in Store?
    Kahnert K; Kauffmann-Guerrero D; Huber RM
    Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new hope: the immunotherapy in small cell lung cancer.
    Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
    Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.
    Fernandez-Cuesta L; Sexton-Oates A; Bayat L; Foll M; Lau SCM; Leal T
    Am Soc Clin Oncol Educ Book; 2023 May; 43():e390794. PubMed ID: 37229617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in the treatment of small cell lung cancer.
    Hiddinga BI; Raskin J; Janssens A; Pauwels P; Van Meerbeeck JP
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34261744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research Progress on the Application of Liquid Biopsy in the Diagnosis 
and Treatment of Small Cell Lung Cancer].
    Zhang X; Xu M; Li X; Su Y
    Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):609-614. PubMed ID: 36002198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.